CHICAGO (Reuters) - Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that ...

Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that ...

After an allogeneic stem cell transplant, a recipient’s body faces a daunting task: rebuilding the person’s blood-forming and ...

A surprising discovery reveals that a gene previously thought to accelerate esophageal cancer actually helps protect against it initially. This pivotal study could lead to better prediction and ...

The post’s claim that ivermectin and other antiparasitics can "cure" cancer is also unproven. Neither the FDA nor the World Health Organization have approved ivermectin to treat cancer, but some ...

Novel research has shown that women are frequently denied MRI scans, despite usual recommendations. Read more.

Scientists have analyzed thousands of mutations in the BRCA2 cancer gene, offering crucial insights. This research could help mitigate patient concerns or guide tailored treatments. By utilizing ...

A variant of PCSK9, a gene involved in raising cholesterol, may spur metastasis. An approved antibody might stop it.

Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.

Around 1,200 people with advanced breast cancer could benefit from a decision by NICE to give the go-ahead to a new treatment ...

Ingested microplastics, on the other hand, can disturb the gut microbiome, trigger local inflammation, and increase the risk ...